Latest News

01.23.20

The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial of Tepezza for Thyroid Eye Disease

Source: Horizon Therapeutics

01.22.20

FDA Approves First Treatment for Thyroid Eye Disease

Source: FDA

01.15.20

Analysis: FDA’s Efforts to Speed Drug Approval May Have Led to Less Rigorous Clinical Outcome Requirements

Source: FirstWord

12.31.19

CRST: 2019 Year in Focus

Source: Cataract & Refractive Surgery Today

12.03.19

Johnson & Johnson Vision Introduces Tecnis Toric II 1-Piece IOL as New Monofocal Option for Patients with Astigmatism

Source: Johnson & Johnson Vision

11.18.19

Nidek Launches the YC-200 and YC-200 S Plus in the United States

Source: Nidek

10.12.19

Norlase Enters Ophthalmic Market With Launch of LEAF Ultra-Compact Green Laser Photocoagulator

Source: Norlase

10.11.19

Johnson & Johnson Vision Announces New Data, Products, and Physician Resources at AAO 2019

Source: Johnson & Johnson Vision

10.08.19

Novartis Receives FDA Approval for Beovu for Wet AMD

Source: Novartis

09.30.19

DORC Obtains 510k Clearance for Launch of EVA Upgrade Enhancements

Source: DORC

View more stories